Lawsuits Filed Against GEO, BAYRY and FE – Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 4, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

The GEO Group, Inc. (NYSE:GEO)

CONTACT JAKUBOWITZ ABOUT GEO:
https://claimyourloss.com/securities/the-geo-group-inc-loss-submission-form/?id=9094&from=1

Class Period : February 27, 2020 – June 16, 2020

Lead Plaintiff Deadline : September 8, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) GEO Group maintained woefully ineffective COVID-19 response procedures; (ii) those inadequate procedures subjected residents of the Company’s halfway houses to significant health risks; (iii) accordingly, the Company was vulnerable to significant financial and/or reputational harm; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Bayer Aktiengesellschaft (OTC PINK:BAYRY)

CONTACT JAKUBOWITZ ABOUT BAYRY:
https://claimyourloss.com/securities/bayer-aktiengesellschaft-loss-submission-form/?id=9094&from=1

Lawsuit on behalf of all persons or entities that purchased or otherwise acquired Bayer American Depositary Receipts between May 23, 2016 and March 19, 2019.

Lead Plaintiff Deadline : September 14, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: 1) following its acquisition of Monsanto Company, Bayer could be at risk of suffering billions of dollars in judgments and reputational damage if the lawsuits brought against Monsanto alleging that exposure to its glyphosate-based Roundup product caused cancer were successful, 2) a result, Defendants’ positive statements about the prospects of the Monsanto acquisition and the benefits it would create for Bayer’s business were materially false and/or misleading and/or lacked a reasonable basis.

FirstEnergy Corp. (NYSE:FE)

CONTACT JAKUBOWITZ ABOUT FE:
https://claimyourloss.com/securities/firstenergy-corp-loss-submission-form/?id=9094&from=1

Class Period : February 21, 2017 – July 21, 2020

Lead Plaintiff Deadline : September 28, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the legislative “solutions” that defendants claimed would resolve problems with the Company’s nuclear facilities were centered on an illicit campaign to corrupt high-profile state legislators and thus secure legislation favoring the FirstEnergy; (2) over roughly three years, FirstEnergy and its affiliates funneled more than $60 million to prominent state politicians and lobbyists, including Ohio Speaker Larry Householder, in order to secure the passage of Ohio House Bill 6, which provided a $1.3 billion ratepayer-funded bailout to keep the Company’s failing nuclear facilities in operation; (3) defendants falsely represented that they were complying with state and federal laws and regulations regarding regulatory matters throughout the Class Period, exposing the Company and its investors to the extreme risks of reputational, legal, and financial harm; (4) as a result of defendants’ false statements and omissions, FirstEnergy insiders were able to sell more than $17 million worth of their FirstEnergy shares at artificially inflated prices.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887